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Background
Recent information has shown the importance of the V1/
V2 domain as a target in HIV-1 vaccines. This includes
the localization of epitopes to potently neutralizing anti-
bodies to this region, the demonstration that binding
between a site in V1/V2 and a4b7 receptors facilitates
infection in primary CD4-positive T cells, and the
demonstration that the presence of antibodies binding to
the native form of the V1/V2 domain of HIV-1 gp120
correlated with protection in the RV144 vaccine trial.
These results highlight the need to better understand the
structure and immunological properties of this region, in
order to optimally express the relevant targets in HIV-1
vaccines.
Methods
The native V1/V2 domain of a clade B sequence (CaseA2)
was expressed by fusion to the C-terminus of a 273 aa
fragment of the MuLV gp70 domain. This fusion glyco-
protein was characterized by SDS-PAGE under various
conditions, by radioimmunoprecipitation experiments
with a panel of mAbs directed against V1/V2-specific epi-
topes, and by MALDI-TOF analysis of immunologically
fractionated forms.
Results
SDS-PAGE analysis of this protein after deglycosylation
under non-reducing conditions revealed the presence of a
closely migrating doublet, and mass-spec analysis of the
immunologically fractionated forms suggested that these
consisted of different disulfide-linked conformers. The two
forms reacted differentially with a panel of V1/V2-specific
antibodies and possessed variable reactivity with different
polyclonal sera.
Conclusion
These studies identify a conformational heterogeneity in
the V1/V2 domain that is due to alternative disulfide
bonding patterns. These conformations profoundly affect
the immunoreactivity of this region, and will presumably
influence their immunogenicity as well. Due to the impor-
tance of this region as a target for neutralizing and other-
wise protective antibodies, it is likely that methods for
resolving this heterogeneity would improve the efficacy of
induction of relevant antibodies to this region by HIV Env
vaccines.
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